Intangible Assets and Royalty Agreement Intangible Asssets Activity Summary (Details) - USD ($)			12 Months Ended
		Jan. 29, 2007	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Jan. 05, 2011
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross carrying value			$ 15,627,000	$ 14,776,000
Less Accumulated amortization			(4,864,000)	(3,931,000)
Intangible Assets, Net			10,763,000	10,845,000
Net book value			9,755,000
Amortization of intangible assets			933,000	928,000	$ 1,054,000
Tradenames & Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross carrying value, indefinite lived			1,008,000	1,008,000
Tradenames & Trademarks | Surgical Biologics, LLC
Finite-Lived Intangible Assets [Line Items]
Gross carrying value, indefinite lived						$ 1,008,000
In Process Research & Development
Finite-Lived Intangible Assets [Line Items]
Gross carrying value, indefinite lived			25,000	25,000
In Process Research & Development | Surgical Biologics, LLC
Finite-Lived Intangible Assets [Line Items]
Gross carrying value, indefinite lived						25,000
Patents in Process
Finite-Lived Intangible Assets [Line Items]
Gross carrying value, indefinite lived			$ 1,823,000	1,082,000
Licenses
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives	[1],[2],[3]		10 years
Gross carrying value	[1],[2],[3]		$ 1,009,000	1,009,000
Licenses | Shriners Hospitals for Children and University of South Florida Research Foundation, Inc.
Finite-Lived Intangible Assets [Line Items]
Acquisition price		$ 996,000
Maximum time of approval		30 days
Contingent payments to licensor			$ 200,000
Contingent royalty to be paid to licensor			3.00%
Annual royalty payment		$ 50,000
Net book value			$ 110,000
Licenses | Surgical Biologics, LLC
Finite-Lived Intangible Assets [Line Items]
Gross carrying value	[1],[2],[3]					13,000
Patents & Know How
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives			17 years
Gross carrying value			$ 8,001,000	7,891,000
Patents & Know How | Surgical Biologics, LLC
Finite-Lived Intangible Assets [Line Items]
Gross carrying value						7,690,000
Finite-lived intangible assets, costs			$ 110,000
Customer & Supplier Relationships
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Lives			14 years
Gross carrying value			$ 3,761,000	$ 3,761,000
Customer & Supplier Relationships | Surgical Biologics, LLC
Finite-Lived Intangible Assets [Line Items]
Gross carrying value						$ 3,761,000

[1] Capitalized external legal and other registration costs in connection with internally developed tissue-based patents that are pending. Once issued, the costs associated with a given patent will be included in Patents & Know-How under intangible assets subject to amortization.

[2] On January 29, 2007, the Company acquired a license from Shriners Hospitals for Children and University of South Florida Research Foundation, Inc. in the amount of $996,000. Within 30 days after the receipt by the Company of approval by the FDA allowing the sale of the first licensed product, the Company is required to pay an additional $200,000 to the licensor. Due to its contingent nature, this amount is not recorded as a liability. The Company will also be required to pay a royalty of 3% on all commercial sales revenue from the licensed products. The Company is also obligated to pay a $50,000 minimum annual royalty payment over the life of the license. As of December 31, 2015, this license had a remaining net book value of approximately $110,000.

[3] On January 5, 2011, the Company acquired Surgical Biologics, LLC. As a result, the Company recorded intangible assets for Customer & Supplier Relationships of $3,761,000, Patents & Know-How of $7,690,000, Licenses of $13,000, Trade Names & Trademarks of $1,008,000 and In-Process Research & Development of $25,000. During 2015 approximately $110,000 of additional costs associated with patents granted during the year were capitalized and included in Patents & Know- How subject to amortization.